Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis comes hope. Listen in as experts and patients guide listeners in understanding diagnosis, treatment, and resources available to blood cancer patients. Join Alicia Patten and Lizette Rivera from the Patient Access Education Team at The Leukemia & Lymphoma Society as they explore various survivorship topics.
Listen to The Bloodline with LLS
To subscribe to The Bloodline with LLS, click here.
Recent Episodes
My AML Diagnosis: Elissa’s Story
Join in as Shona sits down with Elissa Baldwin onsite at CancerCon 2019. CancerCon is an annual conference held every year by Stupid Cancer, an organization that provides support to young adult cancer survivors. Elissa is a young adult acute myeloid leukemia (AML) survivor. After a bone marrow biopsy two weeks earlier, she went on a solo trip to Europe and was diagnosed by email while staying in a hostel in Lisbon, Portugal. She was able to book an emergency flight back home to Portland, OR to begin chemotherapy within a week. On this episode, Elissa shares how and when she was diagnosed, the emotional and physical challenges she experienced and how her diagnosis served as inspiration for a career change. She emphasizes the importance of therapy during a cancer diagnosis and continues to serve as a source of encouragement for other young adult survivors.
Support for this episode provided by Jazz Pharmaceuticals.
CAR T-cell Therapy Explained: What Is It and How Does It Work?
Join Alicia and Lizette as they speak with Dr. Rayne H. Rouce. Dr. Rouce is a pediatric hematologist and oncologist at Texas Children’s Cancer Center where she is a member of the Leukemia and Bone Marrow Transplant programs. Specifically, she works as part of a research program called The Center for Cell and Gene Therapy at Baylor College of Medicine, focused on translating targeted T-cell therapies from the bench to bedside, and has been involved in every aspect of CAR T-cell development for clinical use. On this episode, Dr. Rouce explains the process of chimeric antigen receptor T-cell therapy, also known as CAR T-cell therapy. She also explains the role of normal T cells, how re-engineered T cells are expected to perform after being reinfused into the patient, and the lifespan of these re-engineered T cells. Dr. Rouce shares her excitement not only for the future of CAR T-cell Therapy but also for the hope that this therapy provides to many patients and caregivers.
Support for this episode provided by Celgene; Kite, A Gilead Company; and Novartis.
Coping with Cancer as a Couple
Join in as Shona sits down with Ellen Polamero onsite at CancerCon 2019. Ellen is a clinical social worker at City of Hope in Duarte, California. CancerCon is an annual conference held year by Stupid Cancer, an organization that provides support to young adult cancer survivors. This is the fourth year that Ellen has hosted a ‘Couples Coping with Cancer’ session at CancerCon and shares why it is important to her to provide this offering. On this episode, Ellen speaks about the impact of cancer, not only on the specific person that is diagnosed, but on the family unit as a whole and on intimate partners specifically. She describes the challenges a couple may experience, expectations that couples may place on themselves, the importance of communication and various resources available to couples. Ellen shares key takeaways to help couples navigate their cancer journey.
Listen to The Bloodline with LLS
Support for The Bloodline with LLS provided by Amgen; AstraZeneca; Bristol-Myers Squibb; Jazz Pharmaceuticals; Kite, A Gilead Company; Novartis; Pharmacyclics, an AbbVie company and Janssen Biotech; Seattle Genetics and Takeda Oncology.
.
*The information contained in this podcast is for general information purposes only and is subject to change without notice. It is not intended to substitute the advice of your healthcare provider or information provided to you by your insurance carrier.
To listen to Treating Blood Cancers, our podcast for healthcare professionals, click here.